Skip to main content
Sanara MedTech Inc. logo

Sanara MedTech Inc. — Investor Relations & Filings

Ticker · SMTI ISIN · US79957L1008 US Manufacturing
Filings indexed 692 across all filing types
Latest filing 2026-06-04 Regulatory Filings
Country US United States of America
Listing US SMTI

About Sanara MedTech Inc.

https://sanaramedtech.com/

Sanara MedTech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures. The company develops, markets, and distributes a portfolio of surgical, wound care, and skin care products. These evidence-based healing solutions are utilized by physicians and clinicians in hospitals, clinics, and various post-acute care settings. Sanara MedTech's primary focus is on the surgical tissue repair market, aiming to provide leading-edge technologies that put patient care first.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 92% confidence The document is a U.S. SEC Form 8-K “Current Report” disclosing the termination of a material definitive agreement (Item 1.02). It is a routine regulatory filing to report a material corporate event and does not contain financial results, call transcript, proxy materials, or other specialized content. Therefore, it falls under the general regulatory announcements category (RNS).
2026-06-04 English
10-Q - Sanara MedTech Inc. (0000714256) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-12 English
8-K - Sanara MedTech Inc. (0000714256) (Filer)
Earnings Release Classification · 98% confidence The document is a Form 8-K “Current Report” under the Securities Exchange Act, with Item 2.02 titled “Results of Operations and Financial Condition.” It states that the company issued a press release announcing its financial results for the quarter ended March 31, 2026, and furnishes that press release as Exhibit 99.1. This matches the definition of an Earnings Release (ER): an initial announcement of quarterly/periodical financial results (key highlights only). Q1 2026
2026-05-11 English
DEFA14A
Proxy Solicitation & Information Statement
2026-04-17 English
ARS - Sanara MedTech Inc. (0000714256) (Filer)
Annual Report
2026-04-17 English
DEFA14A
Proxy Solicitation & Information Statement
2026-04-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.